- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01453517
A Psychological and Behavioral Intervention for Post-Bariatric Patients
October 13, 2011 updated by: Karen Grothe, Mayo Clinic
Dialectical Behavior Therapy (DBT) for Post-Bariatric Patients Experiencing Weight Regain
The study is designed to test a pilot intervention for bariatric patients who are starting to regain weight after the 1st year post-surgery.
Dialectical Behavior Therapy (DBT), an empirically supported therapy for Borderline Personality Disorder, has also successfully been applied to patients with substance use and binge eating problems.
The purpose of this study is to develop and test a group intervention based on DBT and cognitive behavioral therapy (CBT) techniques for patients engaging in these maladaptive behaviors after surgery with co-occuring weight gain.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Weight regain post bariatric surgery may be due to anatomical, physiological, or psychological and behavioral factors.
One potential psychological and behavioral contributor to poor weight loss outcome following bariatric surgery may be low distress tolerance, characterized by emotional reactivity to stressors and lack of appropriate emotional regulation, and using eating, drinking, or other substances to improve mood.
Recent research indicates that a subset of patients post-surgery experience challenges with subjective bulimic episodes, graze eating, and alcohol misuse; evidence for poorer excess weight loss (EWL) outcomes is associated with graze eating and uncontrolled eating behavior.
This submission is for a pilot project designed to examine the impact of participation in a dialectical behavior therapy (DBT) plus cognitive behavioral therapy intervention delivered post-surgery on weight, psychological, and behavioral outcomes after Roux-en-Y gastric bypass surgery (RYGB) for patients experiencing weight regain relapse with co-occuring disordered eating or substance misuse behaviors.
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria
- regained ≥ 15% of total post-surgical weight lost
- has either disregulated eating, drinking, or misuse of chemical substance
- age 18-75
- ability to participate in group
- completed first Roux-en-Y gastric bypass procedure at Mayo Clinic
Exclusion criteria
- patients with an uncontrolled psychiatric diagnosis
- patients severely impaired by drug or alcohol use
- completed surgical intervention at location other than Mayo Clinic
- more than one bariatric procedure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change in weight and BMI
Time Frame: weighed at baseline and six weeks [weighed weekly during 6 week intervention]
|
weighed at baseline and six weeks [weighed weekly during 6 week intervention]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
distress tolerance
Time Frame: baseline, posttreatment (within 2 weeks of intervention completion) [measured over an average of 10-12 weeks]
|
emotion regulation and distress tolerance(Distress Tolerance Scale)
|
baseline, posttreatment (within 2 weeks of intervention completion) [measured over an average of 10-12 weeks]
|
|
Mood
Time Frame: baseline, weekly during 6-week intervention, posttreatment (within 2 weeks of intervention completion)[measured over an average of 10-12 weeks]
|
Baseline and posttreatment measure: Structured Clinical Interview for DSM Disorders (SCID)-I Mood Module) Weekly during 6-week intervention: Beck Depression Inventory II
|
baseline, weekly during 6-week intervention, posttreatment (within 2 weeks of intervention completion)[measured over an average of 10-12 weeks]
|
|
Maladaptive eating and purging
Time Frame: baseline, weekly during 6-week intervention, posttreatment (within 2 weeks of intervention completion)[measured over an average of 10-12 weeks]
|
Baseline and posttreatment measures: Eating Disorder Diagnostic Scale, modified Eating Disorder Examination-Q Weekly during 6-week intervention: modified Eating Disorder Examination-Q, food diary, number of eating episodes and number of snacks to quantify graze eating
|
baseline, weekly during 6-week intervention, posttreatment (within 2 weeks of intervention completion)[measured over an average of 10-12 weeks]
|
|
Alcohol consumption
Time Frame: Baseline, weekly during 6-week intervention,posttreatment (within 2 weeks of intervention completion) [measured over an average of 10-12 weeks]
|
Baseline: SCID-I Substance Module Weekly during 6-week intervention: quantity, frequency, type of substance use
|
Baseline, weekly during 6-week intervention,posttreatment (within 2 weeks of intervention completion) [measured over an average of 10-12 weeks]
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karen Grothe, PhD, LP, Mayo Clinic
- Principal Investigator: Susan Himes, PhD, Lifespan/Brown Medical School
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
August 1, 2011
Study Completion (Actual)
August 1, 2011
Study Registration Dates
First Submitted
September 27, 2011
First Submitted That Met QC Criteria
October 13, 2011
First Posted (Estimate)
October 18, 2011
Study Record Updates
Last Update Posted (Estimate)
October 18, 2011
Last Update Submitted That Met QC Criteria
October 13, 2011
Last Verified
October 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-004976
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Behavioral intervention for regain after bariatric surgery
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Sana Klinikum OffenbachWuerzburg University Hospital; Kuwait University; Cleveland Clinic Florida; SRH...CompletedBariatric Surgery Status in T1DGermany
-
Indiana Kidney Stone InstituteIndiana University School of MedicineCompleted
-
University of MinhoHospital de Braga; Universidade do Porto; Fundação para a Ciência e a Tecnologia and other collaboratorsActive, not recruitingEating Behavior | Obesity Adult OnsetPortugal
-
Assistance Publique - Hôpitaux de ParisCompletedBariatric Surgery | Nutritional Deficiency in Pregnancy (Disorder)
-
Istanbul UniversityCompletedAnorexia Nervosa | Bariatric Surgery | Weight Change, Body
-
Assuta Medical CenterCompleted
-
The Hospital of VestfoldSouth-Eastern Norway Regional Health AuthorityCompletedHypertension | Diabetes Mellitus | Obstructive Sleep ApneaNorway
-
Carsten DirksenUniversity of Copenhagen; University of Oxford; University of Southern Denmark; Copenhagen Trial Unit, Center for Clinical Intervention ResearchRecruiting
-
University of BirminghamNational Institute for Health Research, United KingdomUnknownIdiopathic Intracranial HypertensionUnited Kingdom